Venrock Healthcare Capital Partners Buys More Shares of Altimmune

5/29/20

By Niloofer Shaikh, SeekingAlpha

Venrock Healthcare Capital Partners acquired an aggregate 1.3M common shares of Altimmune (NASDAQ:ALT) at a weighted average price ranging from $8.40 to $9.39.

The fund now owns 3M shares of the company.

ALT +16.1% premarket.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.

Connect with these Baltimore Professionals on LinkedIn

  • Edwin Warfield

    Editor in Chief, Warfield Digital

    Connect

  • Jean Halle

    Independent Consultant

    Connect

  • Larry Lichtenauer

    President of Lawrence Howard & Associates

    Connect

  • Newt Fowler

    Partner at Womble Carlyle, LLP

    Connect

  • David Crowley

    Owner at Develop DC

    Connect

  • Carolyn Stinson

    Stinson Marketing Group

    Connect
Feature Your Profile Here